ImmuCell Corporation Deferred Income Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-30
- ImmuCell Corporation deferred income tax expense (benefit) for the quarter ending 2014-12-31 was $57.86K.
- ImmuCell Corporation deferred income tax expense (benefit) for the quarter ending 2014-09-30 was $20.73K, a 7.59% increase year-over-year.
- ImmuCell Corporation deferred income tax expense (benefit) for the quarter ending 2014-06-30 was -$181.37K, a 4614.96% decline year-over-year.
- ImmuCell Corporation deferred income tax expense (benefit) for the quarter ending 2014-03-31 was $14.24K, a 91.44% decline year-over-year.
- ImmuCell Corporation deferred income tax expense (benefit) for fiscal 2025 was $0.00.
- ImmuCell Corporation deferred income tax expense (benefit) for fiscal 2024 was $0.00.
- ImmuCell Corporation deferred income tax expense (benefit) for fiscal 2022 was $7.67K, a 16.29% decline from fiscal 2021.
- ImmuCell Corporation deferred income tax expense (benefit) for fiscal 2021 was $9.16K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | ||||
| 2022-12-31 | $7.67K 10-K · filed 2023-03-29 | ||||
| 2021-12-31 | $9.16K 10-K · filed 2023-03-29 | ||||
| 2020-12-31 | -$10.14K 10-K · filed 2022-03-30 | -$14.63K 10-K · filed 2021-03-30 | |||
| 2019-12-31 | $24.68K 10-K · filed 2021-03-30 | ||||
| 2018-12-31 | $462.44K 10-K · filed 2020-03-27 | ||||
| 2017-12-31 | -$284.81K 10-K · filed 2019-03-22 | ||||
| 2016-12-31 | $236.29K 10-K · filed 2018-03-29 | ||||
| 2015-12-31 | $847.16K 10-K · filed 2017-03-30 | ||||
| 2014-12-31 | $57.86K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $78.59K derived: sum of 2 quarters · filed 2016-03-25 | -$102.78K derived: sum of 3 quarters · filed 2016-03-25 | -$88.54K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $20.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$160.64K derived: sum of 2 quarters · filed 2014-11-12 | -$146.40K 10-Q · filed 2014-11-12 | -$248.51K derived: sum of 4 quarters · filed 2016-03-25 | |
| 2014-06-30 | -$181.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$167.13K 10-Q · filed 2014-08-13 | -$269.24K derived: sum of 3 quarters · filed 2016-03-25 | -$249.97K derived: sum of 4 quarters · filed 2016-03-25 | |
| 2014-03-31 | $14.24K 10-Q · filed 2014-05-14 | -$87.87K derived: sum of 2 quarters · filed 2016-03-25 | -$68.61K derived: sum of 3 quarters · filed 2016-03-25 | -$64.59K derived: sum of 4 quarters · filed 2016-03-25 | |
| 2013-12-31 | -$102.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$82.84K derived: sum of 2 quarters · filed 2016-03-25 | -$78.83K derived: sum of 3 quarters · filed 2016-03-25 | $87.56K 10-K · filed 2016-03-25 | $87.17K 10-K · filed 2014-03-26 |
| 2013-09-30 | $19.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $23.28K derived: sum of 2 quarters · filed 2014-11-12 | $189.67K 10-Q · filed 2014-11-12 | $202.36K derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-06-30 | $4.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $170.41K 10-Q · filed 2014-08-13 | $183.09K derived: sum of 3 quarters · filed 2015-03-26 | $151.75K derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-03-31 | $166.39K 10-Q · filed 2014-05-14 | $179.08K derived: sum of 2 quarters · filed 2015-03-26 | $147.73K derived: sum of 3 quarters · filed 2015-03-26 | $159.35K derived: sum of 4 quarters · filed 2015-03-26 | |
| 2012-12-31 | $12.69K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$18.66K derived: sum of 2 quarters · filed 2015-03-26 | -$7.04K derived: sum of 3 quarters · filed 2015-03-26 | $101.93K 10-K · filed 2015-03-26 | $94.37K 10-K · filed 2013-03-28 |
| 2012-09-30 | -$31.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$19.72K derived: sum of 2 quarters · filed 2013-11-13 | $89.25K 10-Q · filed 2013-11-13 | $90.92K derived: sum of 4 quarters · filed 2014-03-26 | |
| 2012-06-30 | $11.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $120.59K 10-Q · filed 2013-08-13 | $122.27K derived: sum of 3 quarters · filed 2014-03-26 | $34.30K derived: sum of 4 quarters · filed 2014-03-26 | |
| 2012-03-31 | $108.97K 10-Q · filed 2013-05-14 | $110.64K derived: sum of 2 quarters · filed 2014-03-26 | $22.68K derived: sum of 3 quarters · filed 2014-03-26 | -$192.40K derived: sum of 4 quarters · filed 2014-03-26 | |
| 2011-12-31 | $1.68K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$86.29K derived: sum of 2 quarters · filed 2014-03-26 | -$301.36K derived: sum of 3 quarters · filed 2014-03-26 | -$302.50K 10-K · filed 2014-03-26 | |
| 2011-09-30 | -$87.97K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | -$303.04K derived: sum of 2 quarters · filed 2012-11-13 | -$304.18K 10-Q · filed 2012-11-13 | -$407.62K derived: sum of 4 quarters · filed 2013-03-28 | |
| 2011-06-30 | -$215.07K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | -$216.21K 10-Q/A · filed 2012-09-07 | -$319.65K derived: sum of 3 quarters · filed 2013-03-28 | -$473.49K derived: sum of 4 quarters · filed 2013-03-28 | |
| 2011-03-31 | -$1.14K 10-Q · filed 2012-05-14 | -$104.58K derived: sum of 2 quarters · filed 2013-03-28 | -$258.41K derived: sum of 3 quarters · filed 2013-03-28 | ||
| 2010-12-31 | -$103.44K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$257.27K derived: sum of 2 quarters · filed 2013-03-28 | -$299.17K 10-K · filed 2013-03-28 | ||
| 2010-09-30 | -$153.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$195.73K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$41.90K 10-Q · filed 2011-08-15 | ||||
| 2009-12-31 | -$213.35K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |